| 221 |
Hematogones as a Prognostic Indicator in Allogeneic Hematopoietic Stem Cell
Transplantation: Single Center Experience |
2017 |
| 222 |
Hematogones as a Prognostic Indicator in Allogeneic Hematopoietic Stem Cell
Transplantation: Single Center Experience |
2017 |
| 223 |
High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis |
2017 |
| 224 |
Impact of Comorbidities on Outcome of Diffuse Large B Cell Lymphoma (DLBCL) |
2017 |
| 225 |
Impact of Comorbidities on Outcome of Diffuse Large B Cell Lymphoma (DLBCL) |
2017 |
| 226 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |
| 227 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |
| 228 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |
| 229 |
Nosocomial hepatitis C infection among hemodialysis patients:
a single center study in Assuit University Hospital |
2017 |
| 230 |
Obesity risk prediction among women of Upper Egypt: The impact of serum
vaspin and vaspin rs2236242 gene polymorphism
|
2017 |